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Abstract 
A novel docking challenge has been set by the Drug Design Data Resource (D3R) in order to predict the 
pose and affinity ranking of a set of Farnesoid X receptor (FXR) agonists, prior to the public release of 
their bound X-ray structures and potencies. In a first phase, 36 agonists were docked to 26 Protein 
Data Bank (PDB) structures of the FXR receptor, and next rescored using the in-house developed GRIM 
method. GRIM aligns protein-ligand interaction patterns of docked poses to those of available PDB 
templates for the target protein, and rescore poses by a graph matching method. In agreement with 
results obtained during the previous 2015 docking challenge, we clearly show that GRIM rescoring 
improves the overall quality of top-ranked poses by prioritizing interaction patterns already visited in 
the PDB.  Importantly, this challenge enables us to refine the applicability domain of the method by 
better defining the conditions of its success. We notably show that rescoring apolar ligands in 
hydrophobic pockets leads to frequent GRIM failures. In the second phase, 102 FXR agonists were 
ranked by decreasing affinity according to the Gibbs free energy of the corresponding GRIM-selected 
poses, computed by the HYDE scoring function. Interestingly, this fast and simple rescoring scheme 
provided the third most accurate ranking method among 57 contributions. Although the obtained 
ranking is still unsuitable for hit to lead optimization, the GRIM-HYDE scoring scheme is accurate and 
fast enough to post-process virtual screening data. 
 
 
Keywords: docking, D3R, Drug Discovery Data resource, Grand challenge  
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Introduction 
Molecular docking is still the most straightforward computational technique to predict three-
dimensional (3-D) atomic coordinates of a protein-ligand complex [1,2].  Any docking attempt is aimed 
at simultaneously solving two questions: (i) What is the conformation of the ligand when bound to its 
target?, (ii) What is the relative orientation of the ligand with respect to its host protein? Almost 35 
years of practice and the development of over 60 different docking methods [3] have considerably 
helped the community to enhance the quality of the answers to the above two questions, and to better 
depict the precise applicability domain of the method. Very soon, computational chemists have 
realized that posing a drug-like low molecular weight ligand to a structurally druggable and reasonably 
rigid cavity is reachable in the large majority of cases [4]. However, rank these docking solutions to 
prioritize the most relevant one in first place is still a major issue [5]. Pushed by massive interest of the 
pharmaceutical industry in structure-based drug design approaches, the docking community has then 
organized various resources to challenge computational chemists to refine both their practices and 
methods. Among the most important resources are the Community Structure Activity Resource 
(CSAR)[6] and the Drug Design Data Resource (D3R) [7] which periodically organize challenges  aimed 
at predicting protein-ligand coordinates prior to the release of their crystal structures, discriminating 
X-ray poses from decoys and scoring/ranking a set of ligands for well-defined targets [8,5,9-14]. 
The first D3R Grand Challenge [13], launched in 2015, was a good opportunity to test in real life 
conditions, our recently-developed graph matching algorithm (GRIM)[15] to rank docking poses. GRIM 
converts protein-ligand atomic coordinates into a graph where each node is matched to an interaction 
pseudoatom (IPA) describing a single protein-ligand interaction (apolar contact, aromatic interaction, 
hydrogen bond, ionic bond, metal chelation). For each interaction, three IPAs are derived, one on the 
ligand-interacting atom, one on the protein-interacting atom and one at the geometric barycenter of 
the later 2 IPAs. Since the graph precisely depicts the corresponding protein-ligand interaction pattern, 
two different protein-ligand complexes can thus be easily compared by using standard graph matching 
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techniques to determine a clique, in other words, the largest maximal common subgraph which 
describes the protein-ligand interaction pattern shared by the two investigated complexes.  This simple 
graph alignment-based method produces a quantitative estimate of the similarity of two protein-
ligand interaction patterns. It can therefore be used to rank docking poses by similarity to any 
reference interaction pattern (e.g. stored in the Protein Data Bank) or to post-process virtual screening 
docking data. In the latter two scenarios and starting from the same set of docking poses, GRIM 
significantly outperformed standard scoring functions in either posing a set of protein ligands or 
enriching virtual screening hits in true ligands [15]. 
In the first D3R challenge, GRIM rescoring of Surflex-poses was ranked 3rd out of 42 submissions for 
the pose-prediction of HSP90 and MAP4k4 inhibitors, respectively [16]. To check the target and ligand 
set dependency of our method, we applied the same strategy to the D3R second challenge consisting 
in (i) pose prediction of 36 agonists of the Farnesoid X nuclear receptor (FXR), (ii) rank/score a set of 
102 FXR agonists by decreasing binding affinity. This novel competition represents a real challenge for 
several reasons: (i) the FXR receptor structure exhibits a flexible binding site whose conformation 
depends on the bound-ligand chemotype [17], (ii) some but not all ligands require a bound water [18], 
(iii) about one third of the new ligands whose pose need to be predicted exhibit a chemotype never 
co-crystallized with the target, (iv) FXR ligands may adopt almost non overlapping poses due to the 
large size and hydrophobic nature of the ligand-binding cavity. 
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Computational Methods 
FXR dataset 
The structures of the FXR apo-receptor (PDB format) and 102 FXR ligands (SD files and SMILES strings, 
Supplementary Table 1) were downloaded from the D3R Grand Challenge 2 website [7] as a zipped 
archive file (417_data_517096.zip).  In addition, 26 agonist-bound FXR X-ray structures were defined 
as templates (Supplementary Table 2) by searching the RCSB Protein Data Bank [19] for the text 
keyword 'FXR' and a known bound ligand, confirmed as a true FXR agonist. Existing hydrogen atoms 
were removed and added again while optimizing both the protonation and tautomeric states of all 
atoms using Protoss [20]. Water molecules were explicitly conserved at the condition that the water 
oxygen atom was closer than 6.5 Å from any ligand heavy atom and that at least two hydrogen bonds 
with either the protein and/or the ligand could be identified assuming a donor-acceptor distance lower 
than 3.5 Å and a donor-hydrogen-acceptor angle higher than 120 deg. Protein (including water atoms) 
and ligand atoms were then separately saved in MOL2 file format in SYBYL-X 2.1.1 [21]. Last, atomic 
coordinates (main chain atoms only) of the 26 protein templates were structurally aligned to that of 
the apostructure provided by the organizers of the D3R Grand Challenge, using the 'Align_Structures' 
module of SYBYL X 2.1.1. 
The  SD files of the 102 ligands to dock were converted in three-dimensional (3-D) atomic coordinates 
with Corina v3.40 [22]. The protonation state of every ligand was assigned at pH 7.4 with Filter v.2.5.1.4 
[23] and verified manually. 3-D coordinates were saved in MOL2 file format. 
 
Docking poses generation 
Ligands were docked to the above mentioned 26 protein structures using Surflex v.3066 [24]. For each 
protein input structure, a protomol was first generated using a list of binding site residues (including 
bound waters) for which at least one heavy atom was closer than 6.5 Å from one co-crystallized ligand 
6 
 
heavy atom.  The protomol is a pseudo-ligand used as a target to generate putative alignments of 
fragments of an input ligand. It utilizes three probes (C=O, NH, CH4) whose positions correspond to 
energetically favored locations for hydrogen bond acceptors, hydrogen bond donors and apolar atoms, 
respectively. 
In order to better define the docking zone, an additional 3 Å voxels of space around the volume 
specified by the protomol (proto_bloat parameter set to 3) was chosen. The degree of buriedness 
(proto_thresh parameter) for the primary volume used to generate the protomol was set to a value of 
0.3. The protein residues side-chains were kept rigid. Other parameters were assigned as default. The 
docking accuracy parameter set –pgeom was used.  The 'pgeom' option starts each docking from four 
initial and different poses to ensure good search coverage, turns on ligand minimization prior to 
docking and after docking (in-pocket minimization), ensures that the returned poses are different from 
one another by at least 0.5 Å rmsd, and saves a total of 20 poses (ranked by Surflex energy score, from 
000 to 019). Each of the 102 FXR ligands was docked to each of the 26 protein structure templates, 
thereby generating a set of 53,040 (102 x 20 x 26) docking poses. Only poses with a predicted Surflex 
score (in pKd unit) higher than 2.0 were kept for further analysis. 
 
GRIM rescoring 
Protein-ligand interaction patterns were generated with IChem [25] for both the 26 X-ray structures 
and the docking poses, and further compared to that of 26 FXR-agonist X-ray templates with GRIM 
[15]. Each alignment was quantified using the empirical GRIMscore [15] (Eq1). 
GRIMscore = 0.5006 + 0.0151.NLig + 0.0039.NCenter + 0.0143.NProt + 0.2098.SumCl – 0.0720.RMSD – 
0.0003.DiffI      (1) 
NLig: number of matched ligand-based IPAs  
Ncent: number of matched centered IPAs 
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NProt: number of matched protein-based IPAs 
SumCl: 
∑ pair weights in clique
∑ all possible pair weights 
 
RMSD: root mean square deviation (in Å) of the matched clique 
DiffI: absolute value of the difference in the number of IPAs between reference and query.   
For every ligand, the five poses with the highest GRIMscore (GRIM-1 to GRIM-5) were retained. 
 
In a previous study [15], the GRIMscore has been determined by fitting the above described six 
parameters to the IShape similarity score [15] parametrized on a training set of 1800 protein-ligand X-
ray structures. In contrast to IShape, the GRIM score shows an excellent and sharp discrimination 
between known similar and known dissimilar complexes [15]. Please note that GRIM assigns a weight 
to each IPA (used in the SumCl parameters), whose value is inversely proportional to the frequency of 
the corresponding interaction among 9877 sc-PDB protein-ligand complexes [13]. 
 
Root-mean square deviations to atomic coordinates 
Root mean square deviations (rmsd) of predicted poses to the X-ray structures, released at the end of 
the first stage of the challenge, were computed using the rms routine of the Surflex package. Rmsd 
were computed only for heavy atoms and included symmetry operations to explicitly account for 
equivalent atoms (e.g. carboxylate oxygen atoms).  One compound (FXR_33) was excluded from the 
pose prediction phase of the challenge due to an oxidation during the co-crystallization process, 
generating a structure in the crystal that did not correspond to that initially provided. 
  
Ligand ranking 
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For each of the 102 FXR ligands (FXR_1 to FXR_102) to rank, the corresponding protein-ligand complex 
with the absolute best GRIMscore was selected and its binding free energy was estimated using the 
HYDE  scoring function [26] (see Eq. 2) implemented in seeSAR [27]. 
𝛥𝐺𝐻𝑌𝐷𝐸
𝑖 =  ∑ 𝛥𝐺𝑑𝑒ℎ𝑦𝑑𝑟𝑎𝑡𝑖𝑜𝑛
𝑖 +  𝛥𝐺𝐻−𝑏𝑜𝑛𝑑
𝑖
𝑎𝑡𝑜𝑚 𝑖       (2)
     
Briefly, the HYDE scoring function relies on atom type-specific hydration and desolvation terms that 
have been carefully calibrated using octanol/water partition coefficients of small molecules. For more 
details on the HYDE scoring energy terms, the reader is referred to the original article [26].  
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Results and Discussion 
Suitability of known PDB interaction patterns for FXR agonist docking 
We first examined the currently available protein-ligand interaction patterns in the PDB by selecting 
25 entries (one having 2 chains considered) corresponding to FXR structures co-crystallized with 26 
agonists of three different chemotypes (Supplementary Table 2). At this step, we only considered FXR 
structures bound to a known agonist for two main reasons: (i) the FXR receptor, like most nuclear 
hormone receptors, is known to change its overall conformation with respect to the functional effect 
of the ligand [28], (ii) the purpose of the current D3R challenge was focused on FXR agonists only. The 
FXR structure in complex with ivermectin (PDBID 4wvd) was discarded from the list because of the very 
unique binding mode of the latter compound [29]. Ivermectin exhibits both a peculiar structure and 
protein-ligand interaction pattern with respect to the 26 X-ray templates as well as the 102 FXR agonist 
to dock. We therefore decided to remove this structure, as we believe it would add more noise than 
true signal to the training set. The remaining 26 X-ray templates, despite evident structural similarities, 
were all kept since the computing effort for docking and GRIM rescoring remains quite negligible. 
For each of the 26 PDB templates, a protein-ligand interaction pattern graph was obtained with IChem 
[25] and a full pairwise similarity matrix was generated, considering GRIMscore as a similarity 
descriptor. The corresponding heat map (Fig. 1) clearly shows three groups according to the 
chemotypes of the bound ligands. Benzimidazoles appear to bind to FXR with a very homogeneous 
interaction pattern evidenced by very high pairwise similarities (GRIMscore > 1.0). For isoxazoles, the 
observed interaction patterns are clearly more diverse with a few highly similar complexes (e.g. 3rut, 
3ruu, and 3p89; pairwise GRIMscore > 1.0) and much more complexes with still statistically significant 
interaction patterns but lower GRIMscores (between 0.7 and 1.0). The binding mode observed in the 
3fxv entry seems to be unique to this group (Fig. 1). Last, the miscellaneous class is characterized by 
two different interaction patterns corresponding to FXR structures crystallized with either cholic acids 
(1osv, 1ot7_A, 1ot7_B, 4qe6) or tetrahydroazepinoindoles (3fli, 1l1b; Fig. 1). 
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To ascertain that the 26 X-ray structures are indeed suitable templates to select high-quality poses for 
the 102 FXR agonists to dock within this challenge, we next cross-docked each of the 26 template 
ligands into the remaining 25 available protein template structures (self-docking was not permitted 
here). For each docking pose, the corresponding interaction pattern graph was compared and 
matched, with the GRIM alignment method [15], to the 25 interaction pattern graphs used as 
references. The benefit of rescoring Surflex poses by GRIM is nicely visible by comparing the root mean 
square deviations (rmsd) to the X-ray structure of the best predicted poses with or without GRIM 
rescoring (Fig. 2). Very high quality poses are picked by the GRIM scoring function for all 26 ligands 
(Fig. 2). With a single exception (PDB entry 1ot7, chain B), all corresponding ligands could be docked 
within 1.0 Å rmsd (median rmsd = 0.607 Å), thereby validating both the docking engine and the GRIM 
rescoring method as suitable for this particular dataset. Conversely, the best poses selected by the 
native Surflex score exhibit a higher and wider distribution of rmsd across the 26 reference ligands (Fig. 
2). The GRIMscores associated to the GRIM-selected poses are also very high (median GRIMscore = 
1.040) and demonstrate that the set of interaction patterns available in the PDB is sufficient to 
precisely pick high-quality docking solutions for previously uncharted ligands [30].  
 
GRIM rescues Surflex for selecting accurate poses for 36 novel FXR agonists 
The first stage of the D3R Grand Challenge 2 aimed at predicting the binding mode of 36 novel FXR 
agonists (Supplementary Table 1) prior to the release of their FXR-bound X-ray coordinates. Out of the 
36 agonists, 25 ligands exhibit chemotypes already crystallized in complex with FXR and thus in the list 
of 26 PDB templates (21 benzimidazoles, two isoxazoles, one tetrahydroazepinoindole, one cholic acid) 
whereas 9 ligands (3 spiro[indoline-3,4'-piperidine]-2-ones, 3 sulfonamides, 3 miscellaneous) exhibit 
chemotypes not yet crystallized with FXR. One compound (FXR_33) was excluded from the dataset 
following organizers' request due to an oxidation of the compound during the co-crystallization 
process. 
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Following our strategy successfully applied in the previous challenge [16], all ligands were first docked 
with Surflex [24] to all PDB templates. We eliminated the poses with a Surflex score inferior to 2.0. The 
remaining poses were then converted into interaction pattern graphs and further compared to the 26 
reference interaction patterns. For each ligand, the 5 poses with the highest GRIMscore values, 
whatever their initial Surflex rank, are last retained. The overall quality of the docking/rescoring 
protocol is judged by the rmsd of the ligand heavy atoms coordinates to the later released X-ray 
coordinates.  GRIM rescoring clearly aids the Surflex docking engine to find high quality poses as 
evidenced by the mean rmsd which is lower for highest ranked GRIM poses, GRIM-1 (rmsd = 3.25 Å), 
with respect to highest ranked Surflex poses, Surflex-1 (rmsd = 4.12 Å; Fig. 3). As already observed in 
the previous challenge [16], the GRIM-1 pose is usually the most accurate. If one considers the absolute 
lowest rmsd pose out of the five proposed by GRIM, there is no significant decrease of the mean rmsd 
(3.08 vs. 3.25 Å; Table 1, Fig. 3), thereby confirming that GRIM rescoring does not necessitate to output 
more than a single solution. However, we have to admit that the obtained results are not entirely 
satisfactory since the mean rmsd is clearly above the threshold value (rmsd = 2.0 Å) generally 
considered as acceptable by the docking community. Considering the absolute lowest rmsd pose out 
of the 520 (20 x 26) generated for each ligand (Table 1, Fig. 3), we clearly evidence that the present 
challenge was not difficult from a pure docking viewpoint since the mean rmsd of the best possible 
pose is really low (rmsd = 1.34 Å; Fig. 3).  The overall quality of the poses is certainly due to the use of 
multiple protein structures (26 in the present case) accounting for the ligand-dependent flexibility of 
the binding site. Scoring these excellent poses appears to be more challenging since neither GRIM nor 
the Surflex scoring function were able to rank them high enough to be selected. GRIM rescoring is 
however definitely better than relying on the original docking score provided by Surflex. 
Analyzing the obtained rmsd values by chemotype, we clearly see that only agonists from the 
benzimidazole series were accurately docked with 18 out of 23 compounds posed with a rmsd below 
2.0 Å (Fig. 4). None of the two isoxazoles (FXR_4, FXR_23) was properly docked although this series 
had already been co-crystallized with the target. Agonists bearing a new chemotype (sulfonamides, 
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spiro compounds, miscellaneous) were systematically misdocked, considering either GRIM or the 
Surflex scoring function. Only the novel tetrahydroazepinoindole (FXR_5) was accurately posed (Fig. 
4). 
Since GRIM rescoring is a knowledge-based approach, we next looked at which preexisting protein-
ligand interaction patterns have been used to select the final poses. As to be expected, GRIM has 
chosen available interaction patterns from the benzimidazole series to rescore docking poses of 
compounds sharing this chemotype (Table 2). Since this series adopt a very homogenous binding mode 
(Fig.1), it is therefore no surprise that most of the new compounds from this series were docked with 
low rmsd values. Similarly, the two isoxazoles were also rescored according to interaction patterns 
from the same chemical series. Nevertheless, our knowledge-based scoring approach failed in 
selecting accurate poses (Table 2). We previously demonstrated that known interaction patterns for 
this chemotype were more diverse (Fig.1), thereby explaining the difficulty to dock such compounds 
(Table 2). Interestingly, the low two-dimensional (2-D) similarity of the new isoxazoles to the existing 
templates (Table 2) may explain the hard attempt of GRIM to find out the existing good poses 
generated by Surflex (Table 1) but not scored high enough. For agonists exhibiting a novel chemotype 
(sulfonamides and spiro compounds), none of the existing interaction patterns was adequate for 
rescoring (Table 2). In most cases, these compounds were rescored considering only shape similarity 
to known templates, as evidenced by the Npol value, which accounts for the number of polar nodes in 
the selected alignment subgraph (Table 2). In GRIM, nodes have seven possible pharmacophoric 
properties corresponding to the encoded interaction type (hydrophobic, aromatic, hydrogen bond 
donor, hydrogen bond acceptor, negative ionisable, positive ionisable, and metal complexation). 
Whereas apolar nodes (hydrophobic, aromatic) describe mostly the shape of the bound ligand, polar 
nodes (remaining five properties) are placed at the location of polar protein-ligand interactions 
(hydrogen and ionic bonds), therefore increasing the confidence for the selected pose. 
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In the present case, the Npol descriptor exhibited quite often a null value, demonstrating that the 
GRIM alignment method has not found a single common protein-ligand polar interaction with the 
template. Among the miscellaneous series, only the novel tetrahydroazepinoindole FXR_5 was 
accurately docked, by similarity to the interaction pattern observed for the 3fli template of the same 
series (Table 2). Last, the cholic acid analog FXR_34 was misdocked, even if four interaction pattern 
templates from the same series were available (1osv, 1ot7_A, 1ot7_B, 4qe6) but not chosen by GRIM 
(Table 2). 
 
Defining good practices for GRIM rescoring: Are docking failures predictable? 
To better delineate the applicability domain of GRIM rescoring, we plotted the observed rmsd of the 
the top-1 GRIM pose with respect to three simple descriptors: GRIMscore, 2-D similarity to the X-ray 
ligand chosen for interaction template matching, and number of conserved polar interactions between 
the selected pose and the template pose (Npol parameter). The corresponding scatter plots (Fig. 5) 
clearly show some conditions that favor GRIM selection. They are here recapitulated by the following 
three rules: 
Rule 1: a very high GRIMscore (> 1.0) generally leads to a low rmsd (< 2.0). There are only four 
exceptions to this rule, one for which the GRIMscore is below the 1.0 threshold (FXR_9) although the 
rmsd is less than 2.0, and three (FXR_13, FXR_18 and FXR_35) for which the rmsd is higher than 2.0 
although the GRIMscore is above 1.0. (Fig. 5A). 
Rule 2: A high 2-D similarity to the template ligand (Tc > 0.6) generally leads to a low rmsd (< 2.0 Å). 
This rule is verified for 31 out of 35 ligands analyzed. There are no cases for which GRIM could prioritize 
a good pose from a template in which the X-rayed ligand had a low 2-D similarity to the compound to 
dock (Fig. 5B). In four cases (FXR_8, FXR_13, FXR_18, FXR-35), a sufficiently high 2-D similarity to the 
template ligand could not guide GRIM to find out a good pose. When this 2-D similarity is low (< 0.60), 
GRIM fails with no exception. Interestingly, such a strong 2-D chemical similarity to PDB templates was 
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not required to properly dock HSP90 and MAP4K4 inhibitors in the previous D3R challenge [16]. This 
rule might thus be dataset-dependent. 
Rule 3: Good poses correspond to interaction patterns with at least two conserved polar interactions 
(Npol ≥2). In this challenge, we prioritized pose selection by the overall GRIMscore. This strategy clearly 
fails in case the common interaction pattern subgraph chosen for pose selection is lacking enough 
polar nodes (NPol parameter). Assuming only shape conservation (Npol = 0), there is only one ligand 
(FXR_7) out of nine that is well docked by GRIM (Fig. 5C). In case Npol is equal to 1 (one common FXR-
agonist polar interaction), no docking success (rmsd <2.0) could be reported as well. It is only when 
Npol is greater or equal to 2 that good rmsd values begin to be observed (Fig. 5C). There are only three 
ligands (FXR_13, FXR_34, FXR_35) for which the rule is not verified despite a Npol value of 3.0. These 
three rules clearly define a strict applicability domain for GRIM rescoring, at least for the present 
dataset of 36 agonists. New challenges will enable to precise whether these rules are transferable to 
new datasets or not.  
 
Reasons for failure 
After the submission of the first set of predictions (stage1: prediction of up to five poses for each 
ligand), X-ray structure of the 36 new agonists in complex with FXR were released. The comparison of 
the corresponding protein-ligand interaction patterns with that of our 26 PDB templates illustrates the 
difficulty of the present challenge (Fig. 6A). With the exception of all benzimidazoles and one 
tetrahydroazepinoindole (FXR_5), all novel FXR agonists adopt an unprecedented binding mode (Fig. 
6A). A molecular explanation to this observation lies in the large (750-1025 Å3) and hydrophobic cavity 
in FXR that is able to accommodate very different and almost non-overlapping agonists. Despite these 
significant hurdles, observed failures to predict binding modes of these ligands are not due to real 
docking issues. Among the set of proposed poses by Surflex, true docking failures (Surflex-best rmsd < 
3.0 Å) were only reported for three ligands (FXR_1, FXR_18 and FXR_23). The case of the isoxazole 
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FXR_23 is perfectly illustrative. The top-1 GRIM pose (Fig. 6B) was generated by analogy of the 
corresponding interaction pattern found on the 3hc5 template of the same chemical series, nicely 
overlapping the aryl-isoxazole moieties of both compounds.  Surprisingly, the disclosed X-ray pose of 
FXR_23 departs considerably from that already seen for FXR isoxazole agonists (Fig. 6B). None of the 
solutions generated by Surflex are similar to this unexpected pose. It is interesting to notice that two 
out of these three ligands are among the less potent agonists of the dataset, with in vitro binding 
affinities in the micromolar range. 
GRIM failed to propose reliable poses for three benzimidazoles (FXR_8, FXR_13, FXR_35) although they 
exhibit the canonical benzimidazole-binding mode (Fig. 6A) and despite the existence of suitable poses 
generated by Surflex (Surflex-best rmsd < 2.0 Å, Table 1). The overall cross-like shape of the ligands as 
well as the exact binding amino acids are found, but the benzimidazole ring that switched to the area 
normally occupied by a cyclohexyl ring (Fig. 6C). In these examples, the GRIM score is dominated by 
the conservation of apolar contacts (in other words, the overall ligand shape) at the cost of an 
important hydrogen bond between the benzimidazole and Tyr373 side chain. The same observation 
applies to most of the scoring failures for which the GRIM-selected pose has been dominated by shape 
conservation (Fig. 5C). The herein described pose selection protocol, biased towards the highest 
GRIMscore is therefore not suited for hydrophobic ligands binding to predominantly apolar cavities. 
Removing poses with no common polar interactions to the chosen template (Npol = 0) before final 
GRIM ranking should avoid some of the above reported failures in the future. 
Altogether, combining Surflex for pose generation and GRIM for ranking remains a robust docking 
strategy. When compared to the 51 other contributions to the first phase of the D3R Grand Challenge 
2, the Surflex/GRIM protocol lies among the top contributions sharing a posing accuracy in the 2-3 Å 
rmsd range (Fig. 7). 
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Ranking  GRIM poses by the HYDE scoring function: Estimating the binding affinity of 102 FXR 
agonists. 
In a second step, the binding affinity of 102 FXR agonists (Supplementary Table 2), including the 36 
ligands (FXR_1-FXR_36) considered for the pose prediction phase and 66 additional ligands (FXR_37-
FXR_102), was predicted and compared to the experimental  affinity data released once the challenge 
was closed.  The GRIM-1 pose of each ligand was thus rescored with the HYDE scoring function [26]. 
This scoring function was chosen because of the very careful estimation of the desolvation 
contributions to the overall binding free energy of a wide array of diverse protein-ligand complexes. 
Importantly, HYDE is not parametrized against any particular training set and provides a balanced 
assessment of the energetics of desolvation considering three atomic physicochemical properties: 
local hydrophobicity, solvent accessible surface, and contact surface area. When applied to the FXR 
dataset of 102 ligands, HYDE scoring of the GRIM-1 pose yielded the third most accurate ranking with 
a Kendall's  ranking coefficient of 0.442 (Fig. 8A) and a Pearson's ρ correlation coefficient of 0.593  
(Fig. 8B). Predicted HYDE binding free energies were systematically higher than that derived from in 
vitro experimental binding affinity data but an overall trend could be confirmed. The current 
performance in affinity ranking is slightly better than that obtained for the previous D3R challenge for 
two different datasets (180 HSP90 inhibitors, 18 MAP4K4 inhibitors) [13], but far from being usable 
for hit to lead optimization, thereby confirming most previous attempts to accurately predict binding 
free energies for a set of heterogeneous compounds [31,11]. Since the observed ranking and 
correlation coefficients were not improved for the subset of benzimidazoles for which docking poses 
are of good quality, consistent failures in predicting binding free energies cannot be attributed to error 
in atomic coordinates but merely to inconsistent treatment of energetics.  
 
 
Conclusions 
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We have herein applied a knowledge-based graph matching method (GRIM) to rank docking poses of 
36 novel FXR agonists. Although the current poses have been generated by Surflex, the rescoring 
protocol is fully independent on any docking tool, at the condition that correct MOL2 file formats can 
be generated. This second D3R docking challenge was significantly more demanding than the previous 
one for the major reason that the large and apolar ligand-binding site of the chosen target (FXR 
receptor) is able to accommodate chemically heterogeneous ligands in many different ways. Docking 
predictions were reasonably accurate (mean rmsd = 1.97 Å) for the class of 21 benzimidazoles already 
co-crystallized with FXR, which exhibited a conserved binding mode. For other chemical classes, the 
existence (isoxazoles) or not (spiroindolines and sulfonamides) of known similar PDB templates, did 
not impact GRIM posing, which was very unsatisfactory (rmsd above 4 Å).  Several reasons could be 
invoked to explain these systematic rescoring failures: (i) the inability of the docking engine to provide 
a single accurate pose for further rescoring, (ii) the impossibility to predict completely novel binding 
modes, (iii) the bias in GRIM rescoring towards poses with the highest protein-ligand interaction 
pattern similarity to that of existing PDB templates, thereby favoring quite often shape matching for 
ligands with a predominant hydrophobic character. 
However, the current challenge has taught us interesting rules to improve future predictions. First, the 
obtained data confirm the well-known bias of fast energy-based scoring functions to rank improper 
poses among the top-ranked solutions. Any knowledge-based rescoring scheme [32-35] similar in spirit 
to GRIM is therefore preferable to relying only on docking scores. In our current rescoring protocol, 
poses with very low predicted binding energies (predicted pkd < 2) were filtered out and not subjected 
to GRIM rescoring. Later, the comparison of the experimental solutions with our predictions 
surprisingly identified several cases where reasonably good poses (rmsd to X-ray pose < 2 Å) were 
rejected for the simple reason that the predicted pkd was below 2. We will therefore remove this filter 
in our next rescoring protocol. 
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Second, GRIM rescoring relies on the existence of a similar protein-ligand interaction pattern in the 
PDB. For unbalanced interaction patterns dominated by apolar contacts, we identified a bias in 
prioritizing shape overlap over the conservation of a few but very important hydrogen bonds or salt 
bridges. As a workaround, we thus propose to eliminate from the set of GRIM selections, any pose for 
which the number of aligned graph polar nodes to the chosen template is below a value of 2. 
Third, rescoring the GRIM highest ranked pose using the HYDE scoring function provided one of the 
most accurate affinity ranking strategy submitted to this challenge.  Due to the overall speed of the 
procedure, we therefore propose to apply this rescoring protocol to virtual screening where GRIM is 
used to prioritize a few thousand ligands to be further rescored with HYDE within a reasonable amount 
of cpu time (ca. 10 s/compound). 
GRIM presents several advantages over alternative knowledge-based rescoring strategies: (i) it can be 
coupled to any docking algorithm, (ii) it does not constrain ligand docking but rewards interaction 
patterns already present among PDB templates, (iii) it takes advantage of ligands with similar binding 
modes and not necessarily similar chemical structures [16], (iv) it can be applied in a target family-
biased pose selection process in which PDB templates from the same protein but also from similar 
targets can be used to store reference interaction patterns, (v) it permits to directly quantify binding 
mode similarity between a predicted protein-ligand complex and any PDB template at a very high 
throughput. 
GRIM is embedded in the IChem toolkit and available for non-profit research at http://bioinfo-
pharma.u-strasbf.fr/labwebsite/download.html. 
 
Supporting information.  
List of 102 FXR agonists, List of FXR-agonist PDB templates. 
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Table 1. Accuracy of pose selection (rmsd in Å to X-ray solution) for 36 FXR agonists 
Compound rmsd to X-ray, Å 
 GRIM-1a GRIM-2b GRIM-3c GRIM-4d GRIM-5e Surflex-1f Surflex-bestg 
FXR_1 4.00 4.14 5.84 4.77 3.90 3.53 3.08 
FXR_2 7.31 7.63 7.77 7.67 8.04 7.10 1.03 
FXR_3 7.76 4.93 8.13 5.94 4.75 6.59 2.16 
FXR_4 3.89 6.50 3.92 6.23 7.35 7.24 1.18 
FXR_5 0.48 0.69 0.51 0.68 0.63 7.50 0.48 
FXR_6 0.75 0.73 0.70 0.76 0.69 1.86 0.70 
FXR_7 1.11 1.10 1.30 1.21 n.a.h 1.52 1.10 
FXR_8 3.88 3.88 6.45 3.87 5.06 1.50 0.98 
FXR_9 1.19 4.78 4.77 6.93 0.89 1.47 0.89 
FXR_10 4.81 4.52 4.80 4.44 n.a. 4.79 1.34 
FXR_11 4.50 2.69 4.48 3.38 4.75 5.05 2.16 
FXR_12 8.66 8.60 8.68 8.85 8.44 6.90 1.29 
FXR_13 4.61 4.60 7.78 4.61 4.66 1.66 1.66 
FXR_14 0.61 0.65 1.57 0.73 1.46 1.28 0.61 
FXR_15 7.81 4.66 5.08 7.80 7.61 7.91 2.02 
FXR_16 5.78 5.78 4.32 5.61 7.95 7.28 1.11 
FXR_17 2.69 5.82 6.14 8.63 6.13 2.80 1.15 
FXR_18 7.57 9.09 7.74 7.56 7.60 7.26 4.18 
FXR_19 1.17 0.79 1.20 4.94 1.20 1.56 0.79 
FXR_20 0.73 1.17 0.93 n.a. n.a. 2.20 0.73 
FXR_21 0.97 0.77 0.76 0.77 0.77 1.53 0.77 
FXR_22 0.79 0.90 2.00 0.68 2.04 1.70 0.68 
FXR_23 7.82 7.81 6.82 6.49 n.a. 7.02 2.92 
FXR_24 0.74 1.39 1.41 1.44 n.a. 2.19 0.74 
FXR_25 1.73 1.73 1.73 5.04 n.a. 5.21 1.42 
FXR_26 1.32 1.35 1.36 1.34 1.34 1.68 1.32 
FXR_27 0.50 0.96 0.76 0.73 0.67 1.80 0.50 
FXR_28 0.62 0.56 0.94 1.15 0.97 2.25 0.56 
FXR_29 0.79 0.84 0.85 0.84 0.82 1.64 0.79 
FXR_30 1.94 1.98 1.97 1.84 1.83 6.07 1.42 
FXR_31 1.82 1.15 1.98 1.17 1.93 2.16 1.15 
FXR_32 2.07 2.06 2.08 2.07 2.06 2.52 1.43 
FXR_34 5.41 4.42 4.48 3.91 n.a. 12.82 2.38 
FXR_35 6.93 6.74 1.10 6.81 4.51 7.04 1.10 
FXR_36 1.25 1.16 1.10 1.20 6.79 1.79 1.10 
Mean rmsd 3.25 3.33 3.47 3.82 3.98 4.12 1.34 
median rmsd 1.94 2.06 2.00 3.89 2.57 2.51 1.11 
a 1st ranked pose according to GRIMscore 
b 2nd ranked pose according to GRIMscore 
c 3rd ranked pose according to GRIMscore 
d 4th ranked pose according to GRIMscore 
e 5th ranked pose according to GRIMscore 
f 1st ranked pose according to Surflex score  
g lowest rmsd pose out of 20 Surflex solutions. 
h not available 
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Table 2. Characteristics of GRIM top-ranked docking poses for 35 FXR agonists 
Ligand Proteina Poseb Templatec GRIMscored Npole Tcf rmsdg 
FXR_1 3olf 6 3olf 0.90 1 0.32 4.00 
FXR_2 3olf 7 3olf 0.78 1 0.55 7.31 
FXR_3 3oki 15 3oki 0.93 0 0.55 7.76 
FXR_4 3rut 8 3rut 0.84 0 0.42 3.89 
FXR_5 3fli 3 3fli 1.11 3 0.77 0.48 
FXR_6 3oki 11 3oki 1.15 3 0.67 0.75 
FXR_7 3ook 0 3ook 1.06 0 0.66 1.11 
FXR_8 3oki 10 3oki 0.94 0 0.76 3.88 
FXR_9 3oof 2 3oof 0.93 3 0.59 1.19 
FXR_10 1osh 3 1osh 0.80 0 0.34 4.81 
FXR_11 3oof 4 3oof 0.81 1 0.51 4.50 
FXR_12 3olf 3 3olf 0.84 0 0.50 8.66 
FXR_13 3oof 5 3oof 1.03 3 0.75 4.61 
FXR_14 3oki 13 3oki 1.25 3 0.63 0.61 
FXR_15 3ook 15 3ook 0.84 0 0.53 7.81 
FXR_16 3omk 1 3omk 0.80 0 0.43 5.78 
FXR_17 3oof 7 3oof 0.80 3 0.46 2.69 
FXR_18 3omk 6 3omk 1.02 0 0.60 7.57 
FXR_19 3oki 8 3oki 1.10 3 0.76 1.17 
FXR_20 3olf 0 3omk 1.06 6 0.69 0.73 
FXR_21 3ook 18 3ook 1.19 3 0.85 0.97 
FXR_22 3oki 3 3oki 1.12 3 0.78 0.79 
FXR_23 3ruu 7 3hc5 0.87 1 0.58 7.82 
FXR_24 3oof 1 3oof 1.17 6 0.85 0.74 
FXR_25 3omk 1 3omk 1.08 3 0.82 1.73 
FXR_26 3oof 6 3oof 1.10 3 0.72 1.32 
FXR_27 3ook 3 3ook 1.39 5 0.98 0.50 
FXR_28 3ook 18 3ook 1.39 9 0.67 0.62 
FXR_29 3ook 10 3ook 1.42 9 0.67 0.79 
FXR_30 3olf 17 3olf 1.07 9 0.75 1.94 
FXR_31 3oof 2 3oof 1.08 3 0.68 1.82 
FXR_32 3ook 14 3ook 1.08 2 0.74 2.07 
FXR_34 3olf 0 3olf 0.89 3 0.47 5.41 
FXR_35 3oof 0 3oof 1.13 3 0.63 6.93 
FXR_36 3olf 11 3olf 1.30 12 0.78 1.25 
a set of protein coordinates used for docking  
b Surflex pose number 
c set of protein-ligand coordinates used as template for graph matching 
d GRIMscore 
e number of polar nodes in the clique  
f 2-D chemical similarity (Tanimoto coefficient) between query and template ligands, calculated from 
166-bit MDL public keys. 
g root mean square deviations (in Å) from X-ray pose 
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Figure legends 
Fig. 1. Heat map of protein-ligand interaction pattern similarity (GRIMscore) among 26 reference FXR-
agonist X-ray structures.  Entries are grouped according to the three chemotypes (benzimidazoles, 
isoxazoles, miscellaneous) of the bound FXR-agonists. Pairwise similarity GRIMscores are calculated 
with IChem v5.2.6, and colored as follows: blue, no similarity (GRIMscore <0.7); yellow, medium 
similarity (0.7 <GRIMscore < 1.0); red, high similarity (GRIMscore > 1.0) 
 
Fig.2 Distribution of root mean square deviations (in Å) from the true X-ray pose, for 26 reference FXR 
agonists docked to 25 FXR X-ray structures. Poses were scored according to GRIMscore or the native 
Surflex scoring function. The boxes delimit the 25th and 75th percentiles, the whiskers delimit the 5th 
and 95th percentiles. The median and mean values are indicated by a horizontal line and a square, 
respectively. Crosses delimit the 1% and 99th percentiles, respectively. Minimum and maximum values 
are indicated by a dash. 
 
Fig.3 Mean root mean square deviations (in Å) from the true X-ray pose, for 35 new FXR agonists 
docked to 26 FXR X-ray structures. Poses were scored according to GRIMscore or the native Surflex 
scoring function. Top ranked poses by GRIM and Surflex are labelled GRIM-1 and Surflex-1, 
respectively. The lowest rmsd pose identified by GRIM and Surflex are labelled GRIM-best and Surflex-
best, respectively. The median values are indicated by a horizontal line, the standard deviation to the 
mean by a whisker.   
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Fig. 4. Root mean square deviations (in Å) of the GRIM-1 pose from the true X-ray pose for 35 novel 
FXR agonists.  
 
Fig. 5. Variation of the root mean square deviations (in Å) to the X-ray poses for 35 FXR agonists as a 
function of three properties: (A) GRIMscore of the pose, (B) 2-D similarity of the FXR agonist to the 
FXR-bound template ligand used by GRIM, (C) number of polar nodes (polar interactions, Npol) in the 
clique common to the protein-FXR ligand docked pose and the protein-ligand PDB template chosen by 
GRIM for pose selection. Docking poses complying to a precise rule are enclosed by a red circle. 
 
Fig. 6. Predicted vs. X-ray protein-ligand interaction patterns for 35 FXR agonists. A) A posteriori 
observed binding mode similarity of 35 novel FXR agonists to 26 known PDB ligands, as a function of 
the root mean square deviations (in Å) of the GRIM-1 pose to the true X-ray structure. For each novel 
FXR-agonist X-ray structure, the highest GRIMscore considering all 26 PDB templates is used to 
quantify binding mode similarity. B) Predicted (cyan sticks) versus X-ray pose (tan sticks) of the agonist 
FXR_23 bound to the FXR receptor (white ribbons). GRIM-1 pose was obtained by docking FXR_23 to 
the 3ruu atomic coordinates and selected according to the similarity of its interaction pattern to that 
of the 3hc5 ligand (light green sticks). Heteroatoms are colored in blue (nitrogen), red (oxygen), yellow 
(sulfur) and dark green (chlorine).  C) Predicted (cyan sticks) versus X-ray pose (tan sticks) of the agonist 
FXR_8 bound to the FXR receptor (white ribbons). GRIM-1 pose was obtained by docking FXR_8 to the 
3oki atomic coordinates and selected according the similarity of its interaction pattern to that of the 
3oki ligand (light green sticks). Heteroatoms are colored in blue (nitrogen) and red (oxygen)  
 
Fig. 7. Accuracy of 52 contributions to the stage 1 (pose prediction) of the D3R Grand Challenge 2. The 
accuracy of each contribution is described by the mean rmsd of the highest-ranked pose to the X-ray 
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coordinates of 35 test FXR agonists, released after closing the challenge. Incomplete submissions are 
indicated by white bars. 
 
Fig. 8. Assessment of the GRIM-HYDE rescoring protocol for ranking and affinity prediction of 102 FXR 
agonists. A) Comparison of the GRIM-HYDE protocol with respect to 57 competing contributions in this 
challenge, estimated by the Kendall's ranking coefficient. Error bars were obtained by re-computing 
all statistics in 10,000 rounds of resampling with replacement, where, in each sample, the experimental 
IC50 data were randomly modified based on the experimental uncertainties (data provided by the 
organizers). B) Predicted (Gpred) vs. experimental (Gexp) absolute binding free energies in kJ/mol. 
The red line indicates a linear regression fit of predicted to experimental values. 
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